FDA OKs Drug That Reduces Hot Flashes With Fewer Side Effects

Thursday, 03 Oct 2013 04:31 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. health regulators approved Pfizer Inc's menopause drug Duavee, which the company hopes will reduce hot flashes with fewer side effects than older hormone-replacement therapies.

The Food and Drug Administration said on Thursday it approved the drug to treat women with moderate to severe menopause symptoms and to prevent post-menopausal osteoporosis, a bone disease which can increase the risk of fractures.

The drug, which Pfizer is developing with Ligand Pharmaceuticals Inc, combines bazedoxifene - which belongs to a class of drugs known as selective estrogen receptor modulators, or SERMS - and conjugated estrogens, which are derived from the urine of pregnant horses and contained in Pfizer's menopause drug Premarin.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Health Officials Vow to Stop Ebola From Spreading in US

Tuesday, 30 Sep 2014 20:57 PM

A man who flew from Liberia to Texas has become the first patient infected with the deadly Ebola virus to be diagnosed i . . .

Spacing Between Sibling Births Linked to Autism Risk

Tuesday, 30 Sep 2014 19:13 PM

Children conceived either less than one year or more than five years after the birth of a sibling could be at increased  . . .

Light at Night May Hamper Breast Cancer Treatment: Study

Tuesday, 30 Sep 2014 19:08 PM

A study in rats hints that exposure to dim light at night may make human breast cancer tumors resistant to the chemother . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved